Cubist Pharmaceuticals recalls
FDA enforcement reports naming Cubist Pharmaceuticals, Inc. as the recalling firm.
- Recall reports
- 4
- Class I (serious)
- 4
- Most recent report
- Nov 5, 2014
- Nov 5, 2014CUBICIN (daptomycin for injection) 500 mg, For Intravenous Use Only, Rx Only, Single u…Drug · Cubist Pharmaceuticals, Inc.Presence of Particulate Matter: Foreign particulate matter (tiny black specs) were observed at the bottom of the vial following reconstitution.Class I
- Oct 8, 2014CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for:…Drug · Cubist Pharmaceuticals, Inc.Presence of Particulate Matter: Potential presence of glass particulate matter in the vials.Class I
- Jun 18, 2014CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for:…Drug · Cubist Pharmaceuticals, Inc.Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.Class I
- Jan 29, 2014Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials,…Drug · Cubist Pharmaceuticals, Inc.Presence of Particulate Matter; Glass particulates observed in vialsClass I